The Benefit Company is a legal designation introduced by the 2016 Stability Law, which indicates those companies that, alongside the purpose of profit, provide by statute for the pursuit of one or more common benefit objectives in a responsible, sustainable and transparent way.
Kolinpharma
®, which has always believed in the public utility of the company and intends to pursue one or more common benefit objectives in the course of its economic activities, operating in a responsible, sustainable and transparent manner towards people, communities and the environment, cultural and social assets and activities, institutions and associations and other stakeholders.
By choosing the form of a benefit company, the company formally integrates these objectives into those of traditional entrepreneurship:
Ethical behaviour
Commitment to the promotion of ethical behaviour by all employees, both internal and external and especially those in contact with medical specialists, in the performance of their work activities;
Value of human capital
Promotion of the value of human capital, ensuring, both towards its own employees and the local community, the adoption of policies of diversity, equity and inclusion;
Development of own staff
Commitment to the professional and personal development of its employees, in pursuit of the well-being of people by creating a working environment suitable for nurturing technical skills and personal interests, implementing, among others, Company training courses on corporate social responsibility for function managers;
Health of employees
Commitment to promote the health of employees, implementing information and prevention programmes through collaboration with associations or research institutions to strive for an improvement in quality of life;
Biosphere and society
Commitment, with the aim of contributing to creating conditions for prosperity for the biosphere and for society, in pursuit of efficiency in energy consumption and reduction of pollution, by measuring the impact of the carbon footprint and then identifying a form of compensation through tree planting.
“Accountability, sustainability and transparency.
Together towards a future of well-being.”
Kolinpharma®is a B Corp Certified
from May 2024
Note on certification
The "B Certification Corporation" is a trademark that is licensed by B Lab, a private non-profit organization, to companies that, like ours, have successfully passed the B Impact Assessment ("BIA") and therefore meet the requirements of B Lab in terms of social and environmental performance, responsibility and transparency.
Please note that B Lab is not a conformity assessment body under Regulation (EU) No. 765/2008 or a national, European or international standardisation body under Regulation (EU) No. 1025/2012. The BIA criteria are distinct and autonomous from harmonised standards resulting from ISO or other standardisation bodies and are not ratified by national or European public institutions.